Place where comments are to be submitted and deadline for submission
Comments may be submitted to the agency contact person that is listed above until the deadline given in the upcoming notice of public hearing. The deadline for submitting comments and the notice of public hearing will be posted on the Wisconsin Administrative Rules Website at http://adminrules.wisconsin.gov after the hearing is scheduled. RULE TEXT
SECTION 1. DHS 115.01 and 115.02 are amended to read:
DHS 115.01 Authority and purpose. This chapter is promulgated under the authority of ss. 253.13 (1), and 227.11 (2), Stats., to specify the congenital and metabolic disorders for which newborn infants are to be screened by means of a sample of blood taken from an infant shortly after birth and tests performed on that sample by the state laboratory of hygieneand tested. DHS 115.02 Applicability. This chapter applies to the attending physician licensed under ch. 448, Stats., nurse-midwife certified under s. 441.15, Stats., or other attendant at the birth of an infant born in Wisconsin, to the infant and the infant's parents or guardian, and to the state laboratory which carries out tests on the sample of blood taken from the infant. SECTION 2. DHS 115.03 (3) is repealed and recreated to read:
DHS 115.03 (3) “ICD-10-CM” means the International Classification of Diseases, 10th Revision, Clinical Modification.
SECTION 3. DHS 115.04 (intro.) is amended to read:
DHS 115.04 Congenital and metabolic disorders. Blood samples taken from newborns as required underPursuant to s. 253.13 (1), Stats., each newborn shall be tested by the state laboratory for all of the following conditions: SECTION 4. DHS 115.04 (1) is renumbered DHS 115.04 (1) (a) and amended to read:
DHS 115.04 (1) (a) Phenylketonuria (PKU), ICD-9-CM 270.1ICD-10-CM-E70.0.
SECTION 5. DHS 115.04 (1) (b) is created to read:
DHS 115.04 (1) (b) Hyperphenylalaninemia, ICD-10-CM-E70.1
SECTION 6. DHS 115.04 (2) and (3) are amended to read:
DHS 115.04 (2) Galactosemia, ICD-9-CM 271.1 ICD-10-CM-E74.21.
(3) Congenital hypothyroidism, ICD-9-CM 243ICD-10-CM-E03.1.
SECTION 7. DHS 115.04 (4) is repealed and recreated to read:
DHS 115.04 (4) Hemoglobinopathies, including all of the following:
(a) Sickle cell disease, ICD-10-CM-D57.1.
(b) Hemoglobin S-beta Thalassemia, ICD-10-CM-D57.40.
(c) Hemoglobin SC disease, ICD-10-CM-D57.20.
(d) Hemoglobin disease other, ICD-10-CM-D58.2.
SECTION 8. DHS 115.04 (5) to (7) are amended to read:
DHS 115.04 (5) Biotinidase deficiency, ICD-9-CM 266.9ICD-10-CM-D81.810.
(6) Congenital adrenal hyperplasia, ICD-9-CM 255.2 ICD-10-CM-E25.0.
(7) Cystic fibrosis, ICD-9-CM 277.0 ICD-10-CM-E84.9
SECTION 9. DHS 115.04 (8) is repealed and recreated to read:
DHS 115.04 (8) Fatty acid oxidation disorders, including all of the following:
(a) Medium-chain acyl-CoA dehydrogenase deficiency, ICD-10-CM-E71.311.
(b) Long-chain L-3-Hydroxy acyl-CoA dehydrogenase deficiency, ICD-10-CM-E71.318.
(c) Very long-chain acyl-CoA dehydrogenase deficiency, ICD-10-CM-E71.310.
(d) Carnitine palmitoyltransferase II deficiency, ICD-10-CM-E71.318.
(e) Carnitine-acylcarnitine translocase deficiency, ICD-10-CM-E71.318.
(f) Glutaric acidemia type II, ICD-10-CM-E71.313.
(g) 2, 4-Dienoyl-CoA reductase deficiency, ICD-10-CM-E71.318.
(h) Carnitine uptake defect, ICD-10-CM-E71.41.
(i) Medium/short-chain hydroxy CoA dehydrogenase deficiency, ICD-10-CM-E71.318.
(j) Medium-chain ketoacyl-CoA thiolase deficiency, ICD-10-CM-E71.318.
SECTION 10. DHS 115.04 (9) to (14) are amended to read:
DHS 115.04 (9) Maple Syrup Urine Disease, ICD-9-CM 270.3ICD-10-CM-E71.0.
(10) Homocystinuria, ICD-9-CM 270.4ICD-10-CM-E72.11.
(11) Tyrosinemia types I, II, and III, ICD-9-CM 270.2 ICD-10-CM-E70.21.
(12) Citrullinemia types I and II, ICD-9-CM 270.6 ICD-10-CM-E72.23.
(13) Argininosuccinic Acidemia, ICD-9-CM 270.6 acidura, ICD-10-CM-E72.22.
